Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Modernization and the Rising Burden of IBD: New Insights From a Global Study
FDA Approves Novel Blood Test for Alzheimer’s Detection
Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?